News

AUDIO: Are you using these treatments for your patients with actinic keratoses?


 

EXPERT ANALYSIS FROM THE CARIBBEAN DERMATOLOGY SYMPOSIUM

ARUBA – Patients with actinic keratoses are a fixture in most dermatology practices, but is your practice up to date on the full range of treatments available?

At the Caribbean Dermatology Symposium, Dr. David Pariser presented a quick run-down of current, new, and up-and-coming treatments for AKs, including, but not limited to, cryosurgery and imiquimod.

Also, he discusses his experience with field therapy to treat AKs.

"The damage that occurred that caused the actinic keratosis in one specific spot has also occurred in adjacent areas," that can’t be detected visually, he said.

Dr. Pariser is a professor of clinical dermatology at Eastern Virginia Medical School in Norfolk, and a physician in a private group practice in Virginia.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

Fewer than 1% of doctors mention sunscreen to patients
MDedge Dermatology
Restrict Mohs surgery or risk drop in reimbursement
MDedge Dermatology
Novel PDT method proves superior for difficult AKs
MDedge Dermatology
Ingenol mebutate improves outcomes in actinic keratosis
MDedge Dermatology
Photodynamic therapy: ‘Often not worth the trouble’
MDedge Dermatology
VIDEO: Photodynamic therapy pearls can improve results
MDedge Dermatology
ARB, ACE inhibitor at discharge curb heart failure readmissions
MDedge Dermatology
What’s old is new again for actinic keratoses treatment
MDedge Dermatology
Field Therapy in the Treatment of Actinic Keratosis
MDedge Dermatology
Adjunctive ingenol mebutate gel for actinic keratosis caused few side effects, increased compliance
MDedge Dermatology